Skip main navigation

Official websites use .mil
A .mil website belongs to an official U.S. Department of Defense organization.

Secure .mil websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .mil website. Share sensitive information only on official, secure websites.

Skip to main content

Military Health System

TRICARE Policy Manual 6010.63-M, April 2021
Other Services
Chapter 8
Section 20.2
Transcutaneous Electrical Nerve Stimulation (TENS) Devices
Issue Date:  June 9, 2026
Copyright:  HCPCS Level I/CPT only © 2006 American Medical Association (or such other date of publication of CPT). All Rights Reserved.
Revision:  C-53, June 10, 2026
1.0  DESCRIPTION
A TENS device is a small, wearable, battery-operated device that uses electrical impulses to relieve pain. TENS is a non-invasive technology that involves the application of adhesive electrodes to the skin at painful parts of the body. TENS devices may have one electrode with two lead wires that connect the electrode to the device, or two electrodes with four lead wires that connect the electrodes to the device. TENS may be administered by a clinician in a hospital or outpatient setting, or self-administered by a beneficiary at home. Over-the-counter TENS units are widely available for purchase.
2.0  POLICY
2.1  TENS devices and supplies that are approved or cleared by the United States (U.S) Food and Drug Administration (FDA) may be cost-shared for the treatment of the following conditions:
2.1.1  Acute post-operative pain.
2.1.1.1  Cost-sharing is limited to 30 days (one month’s rental) from the day of the surgery.
2.1.1.2  For beneficiaries whose acute post-operative pain lasts longer than 30 days, cost-sharing of TENS devices requires monthly documentation of medical necessity by a TRICARE authorized provider as defined by 32 CFR 199.2, not to exceed 90 days (three one-month rentals) from the day of the surgery.
2.1.1.3  The device must be prescribed within the first 30 days from the day of the surgery.
2.2  TENS devices and supplies are excluded from coverage for the treatment of any condition not listed under paragraph 2.1.
3.0  REPLACEMENT SUPPLIES
3.1  For TENS units with two leads:
3.1.1  A maximum of one unit of replacement supplies (A4595, i.e., electrodes; conductive paste/gel; tape or other adhesives; adhesive remover; skin preparation materials; batteries; and battery chargers) is covered per month, not to exceed 90 days (three months); and
3.1.2  A maximum of one unit of replacement leads (A4557) is covered per episode of care, not to exceed 90 days (three months) from the day of the surgery.
3.2  For TENS units with four leads:
3.2.1  A maximum of two units of replacement supplies (A4595, i.e., electrodes; conductive paste/gel; tape or other adhesives; adhesive remover; skin preparation materials; batteries; and battery chargers) is covered per month, not to exceed 90 days (three months); and
3.2.2  A maximum of two units of replacement leads (A4557) is covered per episode of care, not to exceed 90 days (three months) from the day of the surgery.
3.3  Conductive garments for the delivery of TENS (E0731) are covered only if all of the following conditions are met:
3.3.1  A TRICARE authorized provider has prescribed the garment for use in delivering covered TENS treatment; and
3.3.2  The beneficiary has a documented skin condition which precludes the use of conventional electrodes, adhesive tapes, and lead wires; or
3.3.3  The beneficiary cannot receive treatment without a conducive garment because:
•  There is a large area or many sites to be stimulated, making the use of conventional electrodes, adhesive tapes, and lead wires impracticable; or
•  The stimulation must be delivered so frequently that the use of conventional electrodes, adhesive tapes, and lead wires is impracticable.
4.0  EXCLUSIONS
4.1  Effective June 1, 2020, TENS devices and supplies for home use, prescribed during the course of physical therapy, for the treatment of acute, subacute, and chronic low back pain (LBP) are excluded. See Chapter 7, Section 18.2 for physical therapy that includes the use of TENS treatment.
4.2  Effective July 1, 2026, TENS devices and supplies for the treatment of chronic post-operative pain are excluded.
4.3  Effective July 1, 2026, TENS devices and supplies are excluded for the treatment of all conditions not listed under paragraph 2.1.
5.0  EFFECTIVE DATE
January 12, 2024, for the treatment of acute post-operative pain.
- END -
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery